Effects of remimazolam combined with remifentanil on quality of recovery after ambulatory hysteroscopic surgery: a prospective, observational study
Anesthesia and Pain Medicine · 31.01.2024 · 19 (1) · 44-53
DOI: 10.17085/apm.23102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anesthesia and Pain Medicine, erschienen am 31.01.2024. Verfasst von Insun Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Remimazolam, a new benzodiazepine, is known for its quick onset of effects and recovery time. Recently, it has been licensed for general anesthesia and sedation in Korea and its use is increasing in other countries. However, less is known about its effect on postoperative recovery. We used a patient-reported outcome questionnaire to examine the effect of remimazolam on postoperative recovery.
Methods
Patients who underwent hysteroscopy on day surgery basis were administered an induction dose of remimazolam 6 mg/kg/h followed by a maintenance dose of 1–2 mg/kg/h. After surgery, the translated Korean version of 15-item Quality of Recovery scale (QoR-15K) including post-discharge nausea and vomiting (PDNV) and/or pain, was surveyed 24 h after surgery to evaluate patient recovery.
Results
Total of 38 patients were enrolled in this prospective, observational study. All patients successfully completed QoR-15K. Only one patient scored low for moderate pain and PDNV. On average, patients scored 9 and above for all QoR-15K items except for moderate pain (8.66 ± 1.68). When QoR-15K items were grouped into dimensions, all dimensions scored an average of 9 or higher on a 10-point scale. In addition, 19 out of 38 patients gave score range of 148 to 150 out of possible 150.
Conclusions
Psychometric evaluation based on postoperative QoR-15K among patients receiving remimazolam shows satisfactory patient recovery profiles without significant pain or PDNV. Considering its effectiveness and safety, remimazolam could be one of useful agents for general anesthesia of day surgery in terms of postoperative recovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Anesthesiology and Pain Medicine, Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu, Korea.
Zitieren
APA
Park, I., Kim, J., Chung, S. H., Na, H. S., & Do, S. H. (2024). Effects of remimazolam combined with remifentanil on quality of recovery after ambulatory hysteroscopic surgery: a prospective, observational study. Anesthesia and Pain Medicine, 19(1), 44-53. https://doi.org/10.17085/apm.23102
Vancouver
Park I, Kim J, Chung SH, Na HS, Do SH. Effects of remimazolam combined with remifentanil on quality of recovery after ambulatory hysteroscopic surgery: a prospective, observational study. Anesthesia and Pain Medicine. 2024;19(1):44-53. doi:10.17085/apm.23102
BibTeX
@article{Park2024,
author = {Park, Insun and Kim, Junkyu and Chung, Seung Hyun and Na, Hyo-Seok and Do, Sang-Hwan},
title = {Effects of remimazolam combined with remifentanil on quality of recovery after ambulatory hysteroscopic surgery: a prospective, observational study},
journal = {Anesthesia and Pain Medicine},
year = {2024},
volume = {19},
number = {1},
pages = {44--53},
doi = {10.17085/apm.23102}
}
EUVIMED